Danaher Net Profit Margin 2010-2025 | DHR

Current and historical net profit margin for Danaher (DHR) from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Danaher net profit margin for the three months ending March 31, 2025 was .
Danaher Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-03-31 $23.82B $3.77B 15.81%
2024-12-31 $23.88B $3.90B 16.33%
2024-09-30 $23.74B $3.89B 16.39%
2024-06-30 $23.57B $4.20B 17.83%
2024-03-31 $23.74B $4.40B 18.54%
2023-12-31 $23.89B $4.74B 19.85%
2023-09-30 $21.03B $5.87B 27.94%
2023-06-30 $23.07B $6.30B 27.30%
2023-03-31 $24.90B $6.85B 27.50%
2022-12-31 $26.64B $7.10B 26.66%
2022-09-30 $26.60B $6.64B 24.96%
2022-06-30 $26.17B $6.21B 23.72%
2022-03-31 $25.63B $6.29B 24.55%
2021-12-31 $24.80B $6.27B 25.28%
2021-09-30 $28.07B $5.72B 20.39%
2021-06-30 $26.72B $5.45B 20.39%
2021-03-31 $24.80B $4.60B 18.53%
2020-12-31 $22.28B $3.51B 15.75%
2020-09-30 $20.39B $3.57B 17.49%
2020-06-30 $18.89B $3.37B 17.85%
2020-03-31 $18.03B $3.19B 17.68%
2019-12-31 $17.91B $2.94B 16.41%
2019-09-30 $15.56B $2.43B 15.62%
2019-06-30 $16.04B $2.45B 15.26%
2019-03-31 $16.57B $2.41B 14.55%
2018-12-31 $17.05B $2.65B 15.56%
2018-09-30 $16.80B $2.76B 16.44%
2018-06-30 $16.48B $2.67B 16.20%
2018-03-31 $16.01B $2.55B 15.95%
2017-12-31 $15.52B $2.49B 16.06%
2017-09-30 $17.83B $2.38B 13.36%
2017-06-30 $17.43B $2.20B 12.63%
2017-03-31 $17.16B $2.30B 13.41%
2016-12-31 $16.88B $2.55B 15.13%
2016-09-30 $13.57B $2.50B 18.40%
2016-06-30 $12.95B $3.51B 27.09%
2016-03-31 $13.66B $3.55B 25.95%
2015-12-31 $14.43B $3.36B 23.26%
2015-09-30 $18.58B $3.33B 17.92%
2015-06-30 $19.78B $2.61B 13.19%
2015-03-31 $19.78B $2.59B 13.09%
2014-12-31 $19.75B $2.60B 13.16%
2014-09-30 $19.60B $2.73B 13.91%
2014-06-30 $19.56B $2.64B 13.51%
2014-03-31 $19.34B $2.58B 13.36%
2013-12-31 $19.12B $2.70B 14.10%
2013-09-30 $18.83B $2.54B 13.47%
2013-06-30 $18.57B $2.49B 13.40%
2013-03-31 $18.39B $2.47B 13.44%
2012-12-31 $18.26B $2.39B 13.10%
2012-09-30 $18.00B $2.33B 12.96%
2012-06-30 $18.03B $2.31B 12.79%
2012-03-31 $17.12B $2.36B 13.77%
2011-12-31 $16.09B $2.17B 13.50%
2011-09-30 $14.61B $2.08B 14.21%
2011-06-30 $13.25B $2.20B 16.58%
2011-03-31 $12.83B $1.92B 14.97%
2010-12-31 $12.55B $1.79B 14.28%
2010-09-30 $11.78B $1.59B 13.45%
2010-06-30 $11.44B $1.29B 11.28%
2010-03-31 $10.90B $1.21B 11.14%
2009-12-31 $10.52B $1.15B 10.95%
Sector Industry Market Cap Revenue
Medical Medical Services $136.657B $23.875B
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $88.114B 11.37
CVS Health (CVS) United States $76.496B 9.51
Cencora (COR) United States $55.428B 19.28
DiDi Global (DIDIY) China $22.215B 33.71
Natera (NTRA) United States $20.400B 0.00
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $12.620B 13.36
EUROFINS SCIENT (ERFSF) Luxembourg $12.158B 0.00
CochLear (CHEOY) Australia $11.298B 0.00
Doximity (DOCS) United States $10.912B 50.83
Revvity (RVTY) United States $10.655B 18.34
ICON (ICLR) Ireland $10.552B 9.81
Viatris (VTRS) United States $10.317B 3.54
Avantor (AVTR) United States $8.750B 12.71
Medpace Holdings (MEDP) United States $8.519B 22.63
HealthEquity (HQY) United States $8.446B 41.55
Sonic Healthcare (SKHHY) Australia $8.201B 0.00
Charles River Laboratories (CRL) United States $6.822B 13.37
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $4.185B 38.74
Bausch + Lomb (BLCO) Canada $4.171B 24.58
Sotera Health (SHC) United States $3.616B 20.55
Surgery Partners (SGRY) United States $3.029B 39.39
Alignment Healthcare (ALHC) United States $2.948B 0.00
Concentras Parent (CON) United States $2.925B 16.90
Organon (OGN) United States $2.280B 2.42
Ardent Health Partners (ARDT) United States $2.179B 9.29
Progyny (PGNY) United States $1.882B 41.42
Premier (PINC) United States $1.877B 14.24
GeneDx Holdings (WGS) United States $1.815B 69.90
PACS (PACS) United States $1.625B 0.00
GoodRx Holdings (GDRX) United States $1.432B 28.64
Pediatrix Medical (MD) United States $1.278B 9.73
Teladoc Health (TDOC) United States $1.272B 0.00
Establishment Labs Holdings (ESTA) $1.059B 0.00
Agilon Health (AGL) United States $1.056B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
Nutex Health (NUTX) United States $0.967B 14.61
CareDx (CDNA) United States $0.896B 14.00
AMN Healthcare Services Inc (AMN) United States $0.857B 8.02
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.681B 4.59
InnovAge Holding (INNV) United States $0.570B 0.00
Enhabit (EHAB) United States $0.545B 44.83
Auna S.A (AUNA) Luxembourg $0.514B 13.63
Sonida Senior Living (SNDA) United States $0.493B 0.00
LifeMD (LFMD) United States $0.439B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.367B 0.00
SBC Medicals (SBC) United States $0.361B 0.00
Oncology Institute (TOI) United States $0.230B 0.00
Beauty Health (SKIN) United States $0.217B 0.00
Performant Healthcare (PHLT) United States $0.204B 0.00
DocGo (DCGO) United States $0.143B 23.33
Sera Prognostics (SERA) United States $0.090B 0.00
KindlyMD (KDLY) United States $0.083B 0.00
So-Young (SY) China $0.083B 0.00
OncoCyte (OCX) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.071B 0.00
NeueHealth (NEUE) United States $0.062B 0.00
IceCure Medical (ICCM) Israel $0.057B 0.00
Basel Medical Group (BMGL) Singapore $0.049B 0.00
Pheton Holdings (PTHL) China $0.035B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.033B 0.00
Biodesix (BDSX) United States $0.032B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
ModivCare (MODV) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
Intelligent Bio Solutions (INBS) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00